Comparison of the Effect of Preemptive and Post-operative Erector Spina Plane Block on Intraoperative Opioid Consumption and Postoperative Analgesia in Patients Who Will Undergo Elective Thoracotomy Surgery, Guided by the Nociception Level Index (NoL)

Sponsor
Ankara University (Other)
Overall Status
Completed
CT.gov ID
NCT05944523
Collaborator
The Scientific and Technological Research Council of Turkey (Other)
52
1
2
15.9
3.3

Study Details

Study Description

Brief Summary

The patients who will participate in the study will be determined and informed according to the inclusion and exclusion criteria, and the patients who signed the informed consent form will be included in the study.52 patients who will undergo elective thoracotomy surgery will be divided into double-blinded 2 sided as preemptive and postoperative erector spina plane block.

Intraoperative pain status of the patients will be determined by the "Nociception Level Index" device and analgesia will be provided with fentanyl. The primary aim of the study is to compare the intraoperative opioid consumption of two groups with plan block at different times.

In the postoperative period, patient-controlled analgesia device will be given to both groups for rescue analgesia. The opioid consumption of the patients will be controlled in this way in the postoperative period and their pain status will be determined. The secondary aim of the study is to examine the effect of plan block application time on the postoperative period.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Erector Spina Plan Block
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparison of the Effect of Preemptive and Post-operative Erector Spina Plane Block on Intraoperative Opioid Consumption and Postoperative Analgesia in Patients Who Will Undergo Elective Thoracotomy Surgery, Guided by the Nociception Level Index (NoL)
Actual Study Start Date :
Jan 1, 2022
Actual Primary Completion Date :
Jan 1, 2023
Actual Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group 1

The group in which preemptive erector spina plane block was applied

Procedure: Erector Spina Plan Block
Preemptive erector spina plan block and postoperative erector spina plan block were applied to patients undergoing thoracotomy. The effect of the time of application on intraoperative opioid consumption was compared with the Nociception Level Index pain monitor.

Active Comparator: Group 2

The group in which the end of the surgery was applied to the erector spina plane block

Procedure: Erector Spina Plan Block
Preemptive erector spina plan block and postoperative erector spina plan block were applied to patients undergoing thoracotomy. The effect of the time of application on intraoperative opioid consumption was compared with the Nociception Level Index pain monitor.

Outcome Measures

Primary Outcome Measures

  1. The value of Nociception Level Index (NoL) in both preemptive and postoperative groups [Up to 24 hours]

    We aim to determine the effect of preemptive or postoperative application of ESPB ın the amount of intraopioid consumption by Nociception Level Index

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age between 18-65 years

  • ASA classification <4

  • No history of allergy or hypersensitivity to the drugs we use throughout the procedure

  • BMI ≤ 35

  • No history of neuropathy

  • Surgeries other than emergency surgery

  • Volunteer for the study

  • No presence of infection at the injection site

  • No any pyschiatric disease that would prevent the evaluation of the pain score

Exclusion Criteria:
  • Under the age of 18 or over the age of 65

  • ASA classification ≥ 4

  • History of allergy or hypersensitivity to the drugs we use throughout the procedure

  • BMI > 35

  • History of neuropathy

  • Undergoing emergency surgery

  • Not be a volunteer for the study

  • Presence of infection at the injection site

  • Having a pyschiatric disease that would prevent the evaluation of the pain score

  • Pregnancy

  • Undergo surgery again during the postoperative follow-up period for any reason

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Medicine, Ankara University Ankara Turkey 06100

Sponsors and Collaborators

  • Ankara University
  • The Scientific and Technological Research Council of Turkey

Investigators

  • Study Director: Neslihan Alkış, Prof. Dr., Faculty of Medicine, Ankara University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Canan Tokur, Research Assistant, Ankara University
ClinicalTrials.gov Identifier:
NCT05944523
Other Study ID Numbers:
  • CananT
First Posted:
Jul 13, 2023
Last Update Posted:
Jul 13, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Canan Tokur, Research Assistant, Ankara University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2023